Beaupre Darrin 4
4 · IDEAYA Biosciences, Inc. · Filed Mar 4, 2024
Insider Transaction Report
Form 4
Beaupre Darrin
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2024-03-01+160,000→ 160,000 totalExercise: $46.22Exp: 2034-02-28→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.